Clinical Trial Update: SNV1521 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of SNV1521 in participants with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SNV1521

Snippet

Sponsor: Synnovation Therapeutics, Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING